SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIZZOTTO, Lara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.315
AS - Asia 1.498
EU - Europa 988
SA - Sud America 192
AF - Africa 22
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.020
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.244
SG - Singapore 632
CN - Cina 465
DE - Germania 262
BR - Brasile 168
UA - Ucraina 149
IT - Italia 135
HK - Hong Kong 123
GB - Regno Unito 115
TR - Turchia 111
VN - Vietnam 79
FI - Finlandia 71
SE - Svezia 59
RU - Federazione Russa 55
CA - Canada 40
FR - Francia 31
MX - Messico 28
IN - India 21
BE - Belgio 19
CZ - Repubblica Ceca 19
ES - Italia 19
PL - Polonia 18
ID - Indonesia 15
ZA - Sudafrica 13
BD - Bangladesh 11
JP - Giappone 11
NL - Olanda 10
AR - Argentina 9
LT - Lituania 8
RO - Romania 6
AT - Austria 5
IQ - Iraq 5
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
MA - Marocco 3
PK - Pakistan 3
AU - Australia 2
BG - Bulgaria 2
BO - Bolivia 2
CO - Colombia 2
JO - Giordania 2
KE - Kenya 2
KR - Corea 2
MY - Malesia 2
SA - Arabia Saudita 2
TW - Taiwan 2
UZ - Uzbekistan 2
CH - Svizzera 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
MD - Moldavia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SV - El Salvador 1
TH - Thailandia 1
TO - Tonga 1
TZ - Tanzania 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
Totale 6.020
Salva come PNG Salva come JPEG
Città #
Singapore 381
Woodbridge 358
Ashburn 333
Chandler 253
Fairfield 252
Beijing 198
Santa Clara 172
Jacksonville 170
Houston 151
Ann Arbor 150
Hong Kong 123
Seattle 112
Wilmington 100
Cambridge 97
Dallas 89
New York 81
Izmir 62
Los Angeles 62
Munich 61
Ferrara 49
Nanjing 42
Princeton 38
Shanghai 36
Boardman 33
Milan 31
Ho Chi Minh City 30
São Paulo 25
San Diego 23
Bremen 22
London 20
Brussels 19
Buffalo 19
Turku 19
Mexico City 18
Dearborn 17
Helsinki 17
Shenyang 17
Nanchang 16
Warsaw 16
Addison 15
Brno 15
Montreal 15
Denver 14
Hanoi 14
Brooklyn 13
Changsha 13
Frankfurt am Main 13
Stockholm 13
Tianjin 13
Orem 12
San Francisco 12
Johannesburg 11
San Jose 11
Manchester 10
Tokyo 10
Toronto 10
Guangzhou 9
Jiaxing 9
Zhengzhou 9
Chennai 8
Falkenstein 8
Jakarta 8
Jinan 8
Moscow 8
Poplar 8
The Dalles 8
Auburn Hills 7
Chicago 7
Columbus 7
Dortmund 7
Hefei 7
Mountain View 7
Phoenix 7
Reynoldsburg 7
Amsterdam 6
Atlanta 6
Norwalk 6
Orange 6
Rio de Janeiro 6
Bexley 5
Bologna 5
Falls Church 5
Washington 5
Augusta 4
Biên Hòa 4
Boston 4
Calgary 4
Da Nang 4
Guarulhos 4
Lyon 4
Mumbai 4
Olomouc 4
Querétaro 4
Raleigh 4
Redwood City 4
Secaucus 4
Baghdad 3
Des Moines 3
Hebei 3
Kolkata 3
Totale 4.179
Salva come PNG Salva come JPEG
Nome #
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 235
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 218
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 214
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 209
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 205
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 198
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 196
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 193
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 188
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 185
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 181
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 179
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 174
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 173
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 170
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 161
Multiparametric flow cytometric characterization of circulating stem cell subsets in patients with myocardial infarction: correlation with clinical and biological data 159
The complete impairment of factor VII gene expression by the IVS6+1g/t mutation is compatible with a severe but not lethal bleeding disorder 157
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 156
Aberrant splicing reverts a potentially lethal coagulation deficiency caused by a +1g/t splicing mutation 156
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 148
Rescue of coagulation factor VII function by the U1+5A snRNA 145
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 144
Association of the homozygous nonsense mutation R402X in coagulation factor VII with asymptomatic phenotype 143
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 140
Intracellular evaluation of ER targeting elucidates a mild form of inherited coagulation deficiency 136
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 136
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 134
Non-conventional therapeutic strategies for inherited disorders of hemostasis 124
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 120
Diagnostic workup for clinical and prognostic assessment of acute leukemia. 102
The FVII R402X nonsense mutation, associated with an asymptomatic phenotype, is responsible for small amounts of circulating protein with improved coagulant activity 102
Rescue of coagulation factor VII mRNA processing and protein function by engineered U1+5A snRNA 100
null 94
Extended lifespan of normal human B lymphocytes experimentally infected by SV40 or transfected by SV40 large T antigen expression vector 93
Erratum to: Circulating endothelial cells in patients with chronic lymphocytic leukemia: Clinical-prognostic and biologic significance (Cancer (2010) 116, (1926-37)) 89
Naturally occurring truncated proteins: decreased protein secretion and increased activity result in asymptomatic coagulation factor deficiency 87
null 82
“Compensatory” aberrant splicing supports residual expression levels in severe coagulation factor VII deficiency 76
null 64
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII 57
null 42
Totale 6.065
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.109
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.109
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021317 0 0 0 0 0 58 22 56 12 53 81 35
2021/2022442 38 55 27 10 29 18 16 21 9 34 50 135
2022/2023524 49 52 8 80 96 68 28 44 66 2 22 9
2023/2024233 25 26 9 3 12 50 9 12 8 6 3 70
2024/2025986 14 24 73 45 137 107 9 22 162 91 142 160
2025/20261.692 333 113 242 380 468 156 0 0 0 0 0 0
Totale 6.065